ECG Buddy, an AI Electrocardiogram Solution, Showcased to Global Medical Innovation Leaders

ARPI Participates in Mayo Clinic Showcase as the Only Korean Company Among Global Healthcare Innovators View original image

South Korean medical AI company ARPI (CEO Kim Joonghee) has made its presence known on the global stage by being the only Korean participant selected for a world-class medical innovation program.


ARPI participated in the ‘Mayo Clinic Platform Accelerate Showcase’ held in Rochester, Minnesota, USA from April 7 to 8, where the company introduced its AI-powered electrocardiogram analysis solution, ‘ECG Buddy.’ Among the 25 global healthcare companies featured at the event, ARPI was the sole representative from Korea.


Mayo Clinic Platform Accelerate is a global program operated by the prestigious Mayo Clinic, the leading medical institution in the United States. The program focuses on discovering and supporting the growth of next-generation digital healthcare innovators. The showcase brought together key figures in the medical field, including major clinical leaders, executives, investors from Mayo Clinic, and stakeholders from the Minnesota healthcare ecosystem.


During the two-day event, ARPI operated a booth to present ECG Buddy, drawing significant attention and positive feedback from attendees. The ARPI delegation, including CEO Kim Joonghee and Chief Medical Officer (CMO) Cho Youngjin, attended in person and engaged in in-depth networking with global medical innovation leaders, exploring potential future collaborations.


CEO Kim Joonghee commented, “It is deeply meaningful for us to participate as a Korean company in a program hosted by Mayo Clinic, the world’s top medical innovation institution. Through this participation, we have once again confirmed that ECG Buddy possesses sufficient competitiveness and potential on the global stage. We will continue to take on challenges in the international market moving forward.”



ECG Buddy is an AI-based electrocardiogram analysis solution optimized for emergency room environments. It has received both approval from the Ministry of Food and Drug Safety (MFDS) and CE MDR certification, and is currently deployed in more than 90 hospitals in Korea, supporting over 200,000 ECG analyses each month. ARPI plans to accelerate its global market expansion, including in North America, leveraging its emergency room-specialized solution ECG Buddy and ECG Buddy Clinic for outpatient and health screening markets, using its participation in the Mayo Clinic Showcase as a springboard.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing